|
R5
|
Satisfaction with information and its relationship with
adherence in patients with chronic pain
P. Kendrew, F. Ward, D. Buick, D. Wright, R.
Horne
|
|
R6
|
Testing two methods of presenting side effect risk information
about common medicines
P. Knapp, D. C. Berry, D. K. Raynor
|
|
R7
|
From compliance to concordance: meeting the needs of
patients?
P. Bissell, C. May, P. Noyce
|
|
R8
|
Identification of psychosocial factors which influence
patient adherence with antihypertensive medication
C. Lennon, C. M. Hughes, G. D. Johnston, J. C.
McElnay
|
|
R9
|
The association of psychosocial and diabetes factors
to diabetes knowledge
M. T, McClean, J. C. McElnay, W. J. Andrews
|
|
R10
|
Using community pharmacies to evaluate the safety of
a prescription only medicine in an OTC environment: a unique method in
Europe
I. A. Gibb, K. Miller, J. C. Veltri, B. A. Page,
A. Charlesworth, N. Kellett
|
|
R11
|
Analysis of income from prescription charges
R. Walker
|
|
R12
|
Educational strategies to promote evidence based community
pharmacy practice: a cluster randomised controlled trial
M. C. Watson, C. M. Bond, J. M. Grimshaw, J.
Mollison, A. Ludbrook
|
|
R13
|
Factors influencing community pharmacist participation
in clinical audit: A qualitative study of barriers and drivers of change
F. MacRae, M. Bennie, R. M. Parr, J. R. Johnson
|
|
R14
|
Non-dispensing of NHS prescriptions in community pharmacies
E. I. Schafheutle, E. M. Seston, K. Hassell,
P. R. Noyce, M. Nicolson
|
|
R15
|
SIGN guidelines and the management of sore throat in
community pharmacy
A. Campbell, E. M. McGovern, H. Millar, S. M.
Bryson
|
|
R16
|
Variation in the management of PONV and pain in day case
surgery: implications for evidence-based practice
K. Payne, R. Elliott, G. McHugh, E. Moore
|
|
R17
|
Adherence to national recommendations on antibiotic policies
and impact on prescribing in an NHS region
H. E. Seymour, S. L. Brent, K. Snider, V. A.
Hollyoak, J. M. Smith
|
|
R18
|
Pharmaceutical information exchange between primary and
secondary health care professionals and cancer patients
J. C. Scanlan
|
|
R19
|
Pharmacists’ characteristics and their views of
physician-assisted death
E. Hackett, S.-A. Francis
|
|
R20
|
Implementation of statin prescribing guidelines: a cost
effectiveness analysis
J. D. Morgan, D. J. Wright, H. Chrystyn
|
|
R21
|
Structured medication checking workshops: students attitudes
and performance
P. M. Rutter, D. Brown, J. C. Portlock
|
|
R22
|
Can automated dispensing decrease prescription turn-around
time and alter staff work patterns?
P. M. Rutter, D. Brown, J. C. Portlock
|
|
R23
|
Poor correlation between predicted ideal and prescribed
digoxin dose: a community-based pharmacokinetic study in the elderly
K. Holden, W. Sheldon, P. Earle, A. Dawson, J.
Frater
|
|
R24
|
A comparative study of pharmacist and GP management of
anticoagulant therapy following deviation from the target international
normalised ratio
K. Holden, J. Holden
|
|
R25
|
Medicines management and the individual patient
C. Morecroft, J. Cantrill, M. Tully, M. Crossley
|
|
R26
|
A randomised controlled study to quantify the benefits
of community pharmacist interventions on the prescribing of cardiovascular
drugs in general practice
A. Fish, E. Antonazzo, J. P. Reid, C. M. Bond,
T. H. Porteous, T. Scott
|
|
R27
|
A search for socio-economic influences in behaviour and
attitudes to medicines available for self-medication and NHS prescriptions
B. J. Johnson, A. Muir, S. A. Hudson
|
|
R28
|
Working alongside nursing staff to review medication
in nursing homes
J. Hall, D. R. Mottram, C. Cairns
|
|
R29
|
Laxative prescribing during pregnancy in primary care
A. Offia, R. Walker
|
|
R30
|
Continuation of treatment of drug misusers between primary
and secondary care in the South West
C. Bolton, K. Gamble, K. Heer, D. Kalher, R.
Mehta, J. Scott
|
|
R31
|
A novel approach for teaching aseptic processing to pharmacy
undergraduates
C. Abbot
|
|
R32
|
Effect of pharmaceutical pre-assessment on post-operative
interventions
L. Harris, P. A. Walters, C. Costello
|
|
R33
|
Integrating community pharmacy with NHS Direct: evaluation
of a pilot scheme
J. Munro, A. O’Cathain, E. Knowles, J. Nicholl
|
|
R34
|
Headache experience and medication use in primary care
H. F. Boardman, E. Thomas, P. R. Croft, D. S.
Millson
|
|
R35
|
Patient self-reports of potential adverse drug reactions
J. Krska, N. Jarernsiripornkul, P. A. G. Capps,
R. M. E. Richards
|
|
R36
|
Delivering pharmaceutical care: what does it involve?
J. Krska, D. Hansford, D. Jamieson, F. Arris,
J. Cromarty
|
|
R37
|
Obtaining accurate patient-specific perioperative anaesthetic
costs in orthopaedic anaesthesia
S. Al-Ageel, R. Elliott, P. Noyce
|
|
R38
|
Patient knowledge and acceptability of topical corticosteroid
preparation: the role of the pharmacist in patient education
R. Woodford, E. M. Woodford, C. A. Langley, J.
F. Marriott, K. A. Wilson
|
|
R39
|
Antibiotic prescribing for lower respiratory tract infection
within secondary care
E. M. Woodford, J. F. Marriott, K. A. Wilson,
C. A. Langley
|
|
R40
|
A patient-held medication record and a patient medication
profile to support the continuity of acute cancer care
J. Kelly, F. Forrest, S. Hudson
|
|
R41
|
Professional integration within health centre pharmacies
J. Jesson, A. Rashid, K. Wilson
|
|
R42
|
Compliance and adherence as pragmatic concepts: a study
of TB in rural Pakistan
T. W. Rennie, I. Bates, W. McKelvie
|
|
R43
|
Use of health information touchscreens by community pharmacy
users in six local community pharmacies
E. V. Bennett, I. F. Jones
|
|
R44
|
Investigation of community pharmacists’ participation
in a local medicines management project
E. V. Bennett, I. F. Jones
|
|
R45
|
Talk-in-interaction in the community pharmacy setting:
a conversation analytic approach
D. N. John, W. Housley
|
|
R46
|
Mind the gap: how compliance aids increase the distance
between patients and their medicines
J. Nunney, D. K. Raynor
|
|
R47
|
Clinical mediation review by a pharmacist of patients
on repeat prescriptions in general practice
D. Petty, A. G. Zermansky, D. K. Raynor, C. J.
Lowe, A. Vail, N. Freemantle
|
|
R48
|
Adverse drug reactions: mother talk
M. L. Hughes, C. M. C. Whittlesea, D. K. Luscombe
|
|
R49
|
Responding to red eye
E. M. Seston, M. Nicolson, K. Hassell, J. A.
Cantrill, P. R. Noyce
|
|
R50
|
Gender and age influence on prescription and consultation
frequency for multiple sclerosis patients
H. L. Tremlett, J. Evans, C. M. Wiles, D. K.
Luscombe
|
|
R51
|
Developing clinical pharmacy services to prisoners in
Scotland
H. McNulty, L. Braddick, C. Watt, P. Shearin,
A. Mitchell
|
|
R52
|
Anonymously reported medication errors: the tip of the
iceberg
G. F. Cavell, C. A. Oborne
|
|
R53
|
A pilot project on the impact of a community pharmacy
programme providing advice to women initiating HRT therapy
E. M. Scott, J. C. McElnay, A. B. Shirley, K.
Steele
|
|
R54
|
Developing an R&D agenda for pharmacy workforce research
K. Hassell, E. M. Seston
|
|
R55
|
Perceptions of CPD within the pharmacy profession
H. M. Bell, T. A. Maguire, C. G. Adair, L. F.
McGartland
|
|
R56
|
Supplying emergency hormonal contraception in the pharmacy:
the perspectives of service users
C. Anderson, P. Bissell, S. Sharma, R. Sharma
|
|
R57
|
Supplying emergency hormonal contraception through patient
group direction: a qualitative study of the view of pharmacists
P. Bissell, C. Anderson, I. Savage, L. Goodyear
|
|
R58
|
A postal survey to assess the view of community pharmacists
on the deregulation of emergency hormonal contraception
A. Wearn, M. Gray, P. Gill, M. A. Ewan, P. Sandhu,
Z. Rajaei-Dehkordi
|
|
R59
|
The use of sublingual glyceryl trinitrate and aspirin
in angina patients and enhancement of coronary heart disease databases
C. Alford, E. M. Grant, C. Johnston, P. McIntyre
|
|
R60
|
Integrating the community pharmacist into the diabetes
team: evaluation of a new care model for patients with Type 2 diabetes
mellitus
J. Wermeille, M. Bennie, I. Brown
|
|
R61
|
Validity and reliability of the kidney disease questionnaire
in patients receiving continuous ambulary peritoneal dialysis
C. M. Hughes, A. Al-Ghadeer, M. McClean, J. C.
McElnay
|
|
R62
|
Pharmaceutical inspections in nursing and residential
homes: an assessment of the recommendations
A. K. Schweizer, N. B. Curry, C. M. Hughes
|
|
R63
|
The impact of hospital antimicrobial policy on the incidence
of Clostridium difficile infection
A. H. Schober, J. C. McElnay, M. G. Scott, M.
P. Kearney
|
|
R64
|
Attitudes of community pharmacists towards medication
error reporting
G. F. Cavell, V. Burgess, C. A. Oborne, R. Williams,
S. Colwill
|
|
R65
|
The views of general practitioners on the reuse of patients’
own drugs
K. Salmon, J. Whittam, S. Freeborn
|
|
R66
|
Training needs analysis for pharmacy technicians in Northern
Ireland
G. F. Fleming, T. A. Maguire
|
|
R67
|
Compliance, concordance and the revolving door of care:
caring for elderly people with mental health problems
D. Harris, C. Anderson
|
|
R68
|
Cost implications of the use of troponin I (cTnI) measurement
to diagnose heart conditions
C. Scullin, J. C. McElnay, M. G. Scott, M. Ryan,
T. G. Trouton, S. Baird
|
|
R69
|
Do increasing levels of income deprivation have an effect
on the prescribing of OTC medications?
D. Evans
|
|
R70
|
Development and validation of an instrument to measure
professional self-perception and job satisfaction of Portuguese community
pharmacists
A. Cavaco, M. Ayorinde, E. Pentiah, J. P. Sousa
Dias, I. Bates
|
|
R71
|
Implementing a system for tackling under-reporting of
adverse drug reactions within a district general hospital
I. Andrew, S. Baker, A. Chalmers
|
|
R72
|
Futile and inappropriate prescribing: an assessment of
the issue in a series of patients admitted to a specialist palliative
care unit
A. Nicholson, I. Andrew, R. Etherington, R. Gamlin,
T. Lovel, J. Lloyd
|
|
R73
|
Addressing pharmaceutical and medicines management issues
within the cancer network structure
A. Hodgetts, T. Beswick, J. Rimmer, S. Aspley
|
|
R74
|
Identification of the need for pharmaceutical care within
the prevention strategy of CHD: a study in acute MI patients
S. Chinwong, F. Reid, S. McGlynn, S. A. Hudson,
A. D. Flapan
|
|
R75
|
Does social environment affect arthritis patients’
ability to remain on methotrexate treatment?
A. Bayraktar, S. Hudson, A. Watson, S. Fraser,
J. Hunter
|
|
R76
|
Patients’ perspectives on medicines and pharmacy:
the view of patients with Type 2 diabetes
E. Douglas, S. Chapman, S. Hudson, K. Paterson,
C. Duggan
|
|
R77
|
Polypharmacy and asynchronous prescribing in elderly
patients within primary care
D. Clewes, V. Hartzig, C. Langley, J. F. Marriott,
K. Wilson
|
|
R78
|
Concordance in Muslim patients in primary care
A. N. Bashir, M. Asif, F. M. Lacey, C. A. Langley,
J. F. Marriott, K. A. Wilson
|
|
R79
|
Risk assessment of intravenous dose presentation in secondary
care
K. Joshi, E. Graham-Clarke, J. Smith, C. Langley,
J. Marriott, K. Wilson
|
|
R80
|
Identification of the pharmaceutical needs of patients
with heart failure
M. McGinnes, S. McGlynn, A. Watson
|
|
R81
|
Preliminary investigation of the problems associated
with supply of palliative care medicines in primary care
F. Lacey, J. Jesson
|
|
R82
|
Action learning as an improved method for continuing
professional development for pharmacists providing women’s health
care advice
D. P. McAree, E. M. Scott
|
|
R83
|
Major illness consultations: a mismatch of perceptions
C. J. Morris, J. A. Cantrill, M. C. Weiss
|
